Aries Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$324K Sell
896
-2
-0.2% -$685 0.06% 196
2026
Q1
$316K Hold
898
0.07% 183
2025
Q4
$294K Hold
898
0.07% 188
2025
Q3
$253K Hold
898
0.06% 204
2025
Q2
$251K Sell
898
-11
-1% -$3.12K 0.07% 198
2025
Q1
$283K Hold
909
0.08% 189
2024
Q4
$237K Hold
909
0.07% 199
2024
Q3
$293K Buy
+909
New +$297K 0.08% 188
2022
Q2
Sell
-1,200
Closed -$290K 178
2022
Q1
$290K Buy
+1,200
New +$276K 0.13% 67

Other funds holding AMGN

Aries Wealth Management's AMGN Position: Q2 2026 in Review

Aries Wealth Management reduced its Amgen (AMGN) stake by 0.22% in Q2 2026, selling an estimated $685 and leaving 896 shares worth $324K. The position accounts for 0.06% of the portfolio, ranked #196.

Aries Wealth Management first reported a position in AMGN in Q1 2022 and has held it in 9 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Aries Wealth Management held 896 shares of Amgen worth $324K as of Q2 2026.
  • Aries Wealth Management sold 2 Amgen shares in Q2 2026, an estimated $685.
  • Amgen made up 0.06% of Aries Wealth Management's portfolio in Q2 2026, its #196 holding.
  • Aries Wealth Management first reported a position in Amgen in Q1 2022 and has held it in 9 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Aries Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.